VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
USNA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
USNAUSANA Health Sciences, Inc.
$21.01$388M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksUSNAQuarterly Financials

USANA Health Sciences, Inc. (USNA) Quarterly Financials

120+ quarters historyFree accessUpdated daily

USANA Health Sciences, Inc. (USNA) quarterly income statement — complete revenue, gross profit & net income history

USNA Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue250.22M226.2M213.67M235.85M249.54M213.61M200.22M212.87M227.8M221.08M213.37M238.2M248.36M227.96M233.3M264.47M272.87M267.3M274.35M336.84M
Revenue Growth %0.27%5.89%6.72%10.79%9.54%-3.38%-6.16%-10.64%-8.28%-3.02%-8.54%-9.93%-8.98%-14.72%-14.96%-21.48%-11.4%-13.92%-8.09%30.06%
Cost of Goods Sold59.44M49.41M48.81M57.93M60.78M42.55M42.83M44.15M46.23M45.23M45.8M46.55M51.82M49.72M50.03M52.87M54.66M55.8M53.96M60.29M
COGS % of Revenue23.75%21.84%22.85%24.56%24.36%19.92%21.39%20.74%20.29%20.46%21.47%19.54%20.86%21.81%21.45%19.99%20.03%20.88%19.67%17.9%
Gross Profit190.78M176.79M164.85M177.92M188.75M171.06M157.4M168.72M181.57M175.85M167.56M191.66M196.54M178.24M183.27M211.61M218.21M211.5M220.39M276.54M
Gross Margin %76.25%78.16%77.15%75.44%75.64%80.08%78.61%79.26%79.71%79.54%78.53%80.46%79.14%78.19%78.55%80.01%79.97%79.12%80.33%82.1%
Gross Profit Growth %1.07%3.35%4.74%5.45%3.96%-2.72%-6.07%-11.97%-7.62%-1.34%-8.57%-9.43%-9.93%-15.73%-16.85%-23.48%-11.69%-14.81%-7.66%33.1%
Operating Expenses176.91M159.54M163.63M161.2M173.08M162.85M141.79M150.88M156.9M151.63M149.96M167.26M169.7M155.69M160.64M182.24M185.14M179.99M179.62M222.82M
OpEx % of Revenue70.7%70.53%76.58%68.35%69.36%76.24%70.82%70.88%68.88%68.59%70.28%70.22%68.33%68.3%68.85%68.91%67.85%67.34%65.47%66.15%
Selling, General & Admin88.25M78.08M85.95M161.2M173.08M162.85M141.79M150.88M156.9M151.63M149.96M167.26M169.7M155.69M160.64M182.24M185.14M179.99M179.62M222.82M
SG&A % of Revenue35.27%34.52%40.22%68.35%69.36%76.24%70.82%70.88%68.88%68.59%70.28%70.22%68.33%68.3%68.85%68.91%67.85%67.34%65.47%66.15%
Research & Development00000000000000000000
R&D % of Revenue--------------------
Other Operating Expenses1000K1000K1000K00000000000000000
Operating Income13.87M17.25M1.22M16.72M15.67M8.21M15.6M17.84M24.67M24.22M17.61M24.4M26.84M22.55M22.63M29.37M33.07M31.5M40.77M53.72M
Operating Margin %5.54%7.63%0.57%7.09%6.28%3.84%7.79%8.38%10.83%10.95%8.25%10.24%10.81%9.89%9.7%11.1%12.12%11.79%14.86%15.95%
Operating Income Growth %-11.47%110.1%-92.15%-6.29%-36.49%-66.1%-11.39%-26.89%-8.09%7.4%-22.2%-16.91%-18.82%-28.42%-44.49%-45.34%-25.18%-40.03%-10.11%35.7%
EBITDA23.66M27.54M10.79M26.32M25.92M14.09M21.16M23.54M29.76M29.09M22.77M29.54M32.07M27.8M28.05M34.49M38.67M37.17M46.25M59.28M
EBITDA Margin %9.46%12.17%5.05%11.16%10.39%6.6%10.57%11.06%13.06%13.16%10.67%12.4%12.91%12.2%12.03%13.04%14.17%13.9%16.86%17.6%
EBITDA Growth %-8.69%95.37%-49%11.81%-12.91%-51.55%-7.05%-20.31%-7.21%4.63%-18.85%-14.36%-17.08%-25.19%-39.35%-41.81%-22.17%-35.98%-9.21%31.04%
D&A (Non-Cash Add-back)9.79M10.29M9.57M9.6M10.24M5.88M5.56M5.7M5.08M4.87M5.16M5.14M5.22M5.25M5.42M5.13M5.61M5.66M5.48M5.56M
EBIT15.71M4.3M1.84M19.08M17.15M10.56M18.66M20.25M27.16M26.76M20.57M26.85M28.53M22.83M23.26M29.4M33.32M31.66M40.37M54.33M
Net Interest Income197K372K529K360K312K2.61M3.09M2.71M2.62M2.76M2.69M2.18M1.74M1.43M886K577K707K571K469K663K
Interest Income437K495K578K619K723K2.74M3.14M2.76M2.68M2.9M2.73M2.22M1.77M1.46M918K673K739K589K487K679K
Interest Expense240K123K49K259K411K129K49K51K52K145K43K43K31K32K32K96K32K18K18K16K
Other Income/Expense1.59M-13.07M570K2.1M1.07M2.22M3.01M2.36M2.44M2.39M2.92M2.41M1.66M251K594K-58K220K141K-420K590K
Pretax Income15.46M4.18M1.79M18.82M16.74M10.43M18.61M20.2M27.11M26.61M20.53M26.81M28.5M22.8M23.22M29.31M33.29M31.65M40.35M54.31M
Pretax Margin %6.18%1.85%0.84%7.98%6.71%4.88%9.29%9.49%11.9%12.04%9.62%11.26%11.48%10%9.95%11.08%12.2%11.84%14.71%16.12%
Income Tax8.51M5.77M8.46M8.37M7.45M5.95M8M9.77M10.57M9.85M9.18M9.52M10.12M10.01M8.29M10.15M10.82M11.33M13.02M16.08M
Effective Tax Rate %55%138.19%471.35%44.5%44.5%57%43%48.36%39%37%44.73%35.5%35.5%43.89%35.72%34.64%32.5%35.79%32.27%29.6%
Net Income7.51M-1.77M-6.52M9.65M9.4M4.48M10.61M10.43M16.54M16.77M11.35M17.29M18.38M12.79M14.93M19.16M22.47M20.32M27.33M38.23M
Net Margin %3%-0.78%-3.05%4.09%3.77%2.1%5.3%4.9%7.26%7.58%5.32%7.26%7.4%5.61%6.4%7.24%8.23%7.6%9.96%11.35%
Net Income Growth %-20.07%-139.59%-161.49%-7.45%-43.15%-73.26%-6.52%-39.67%-10.04%31.04%-23.99%-9.74%-18.19%-37.03%-45.38%-49.9%-26.62%-48.72%-10.41%36.66%
Net Income (Continuing)6.96M-1.59M-6.66M10.44M9.29M4.48M10.61M10.43M16.54M16.77M11.35M17.29M18.38M12.79M14.93M19.16M22.47M20.32M27.33M38.23M
Discontinued Operations00000000000000000000
Minority Interest51.24M53.17M53.48M54.5M54.11M54.22M00000000000000
EPS (Diluted)0.41-0.10-0.360.520.490.230.560.540.860.870.590.890.950.660.781.001.151.031.361.87
EPS Growth %-16.33%-142.17%-164.29%-3.7%-43.02%-73.56%-5.08%-39.33%-9.47%31.82%-24.36%-11%-17.39%-35.92%-42.65%-46.52%-20.69%-44.92%-5.56%41.67%
EPS (Basic)0.41-0.10-0.360.520.490.230.560.550.860.880.590.900.950.670.781.001.161.041.371.89
Diluted Shares Outstanding18.41M18.3M18.29M18.54M19.09M19.1M19.08M19.16M19.3M19.25M19.37M19.43M19.33M19.26M19.25M19.24M19.48M19.67M20.16M20.45M
Basic Shares Outstanding18.4M18.3M18.29M18.51M19.05M19.06M19.08M19.07M19.17M19.13M19.25M19.3M19.28M19.21M19.22M19.21M19.35M19.39M19.96M20.25M
Dividend Payout Ratio--------------------